A Study to Evaluate Safety of Three Intra-articular Injections of Ampion in the Knee of Adults With Osteoarthritis Pain
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Phase 1 will evaluate the safety of 3 intra-articular injections of Ampion™ administered 2
weeks apart to adults with osteoarthritis of the knee.
In the absence of serious drug-related Adverse Events (AEs) of unanticipated drug-related
AEs, enrollment will be initiated in Phase 2 of the study.
Phase 2 will evaluate the efficacy of 3 intra-articular injections, given 2 weeks apart, of
Ampion™ in Adults with pain due to osteoarthritis of the knee.